Companies / Adamas Pharmaceuticals Inc
Adamas Pharmaceuticals Inc
ADMSCIK 1328143
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 13, 2015 | aeris Capital Equity Investments, L.P. 10% owner | Sell Open-market sale | Common Stock | $6.03M | -350K -17.39% | 1,662,128 | medium |
| May 29, 2015 | Mdv IX LP 10% owner | Sell Open-market sale | Common Stock | $2.02M | -112K -24.72% | 341,328 | medium |
| Apr 10, 2015 | Mdv IX LP 10% owner | Sell Open-market sale | Common Stock | $688.1K | -37K -7.42% | 462,527 | medium |
| Jun 18, 2015 | Mdv IX LP 10% owner | Sell Open-market sale | Common Stock | $436.3K | -16K -4.64% | 325,486 | medium |
| Mar 18, 2015 | Went Gregory T CEO | Sell Open-market sale | Common Stock | $169.6K | -9K -2.25% | 408,328 | medium |
| May 28, 2015 | Mdv IX LP 10% owner | Sell Open-market sale | Common Stock | $134.8K | -7K -1.62% | 453,401 | medium |
| Mar 18, 2015 | Ericson William W. +1 co-filer Director | Sell Open-market sale | Common Stock | $129.9K | -7K -1.42% | 499,605 | medium |
| Mar 12, 2021 | MacPhee John A Director | Exercise Option exercise | Common Stock | $127.7K | +192K +3840.00% | 197,000 | low |